IHS Chemical Week

Markets :: Specialty Chemicals :: Catalysts

Albemarle beats estimates despite sales decline

3:16 PM MST | January 22, 2013 | Vincent Valk

Albemarle’s fourth-quarter net income totaled $37.7 million, or 42 cts/share down 17.1% from the year-ago period, on sales down 2.8% to $687.6 million. Excluding charges related to a change in pension accounting, as well as restructuring charges, adjusted net income totaled $105.2 million, or $1.17/share, beating analysts’ consensus of 99 cts/share, as reported by Thomson Reuters (New York). The decline in sales was driven by lower metals surcharges in the catalysts business, which offset volume growth, Albemarle says.   Catalyst segment sales...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa